{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:19:12Z","timestamp":1789049952265,"version":"build-2803163510"},"reference-count":92,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Veterinary Clinics of North America: Small Animal Practice"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.cvsm.2007.12.002","type":"journal-article","created":{"date-parts":[[2008,2,25]],"date-time":"2008-02-25T20:03:23Z","timestamp":1203969803000},"page":"251-268","source":"Crossref","is-referenced-by-count":86,"title":["Immunopathogenesis of Keratoconjunctivitis Sicca in the Dog"],"prefix":"10.1016","volume":"38","author":[{"given":"David L.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cvsm.2007.12.002_bib1","first-page":"368","article-title":"Evaluation of tear formation in the dog, using a modification of the Schirmer tear test","volume":"166","author":"Gelatt","year":"1975","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2007.12.002_bib2","first-page":"624","article-title":"Keratoconjunctivitis sicca in dogs","volume":"81","author":"Helper","year":"1976","journal-title":"Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib3","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/978-1-4615-5359-5_132","article-title":"Survey of canine tear deficiency in veterinary practice","volume":"438","author":"Kaswan","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib4","unstructured":"Peirce V, Harmer E, Williams DL. Prevalence of keratoconjunctivitis in the canine population: Shirmer tear tests in one thousand normal dogs. Veterinary Journal submitted."},{"key":"10.1016\/j.cvsm.2007.12.002_bib5","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/archopht.1989.01070020276038","article-title":"Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops","volume":"107","author":"Kaswan","year":"1989","journal-title":"Arch Ophthal"},{"key":"10.1016\/j.cvsm.2007.12.002_bib6","series-title":"The cornea","first-page":"439","article-title":"Physiology of the tear film","author":"Lambert","year":"1994"},{"key":"10.1016\/j.cvsm.2007.12.002_bib7","first-page":"218","article-title":"Characteristics of a glycoprotein in the ocular surface glycocalyx","volume":"33","author":"Gipson","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cvsm.2007.12.002_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1542-0124(12)70149-0","article-title":"Character of ocular surface mucins and their alteration in dry eye disease","volume":"2","author":"Gipson","year":"2004","journal-title":"Ocul Surf"},{"key":"10.1016\/j.cvsm.2007.12.002_bib9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.exer.2003.09.003","article-title":"The role of the lacrimal functional unit in the pathophysiology of dry eye","volume":"78","author":"Stern","year":"2004","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.cvsm.2007.12.002_bib10","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.2460\/javma.2000.216.1576","article-title":"Comparison of absorptive capacities of original and modified Schirmer tear test strips in dogs","volume":"216","author":"van der Woerdt","year":"2000","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2007.12.002_bib11","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.2460\/ajvr.2000.61.1422","article-title":"Evaluation of results for Schirmer tear tests conducted with and without application of a topical anesthetic in clinically normal dogs of 5 breeds","volume":"61","author":"Afonso","year":"2000","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cvsm.2007.12.002_bib12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1463-5224.2005.00421.x","article-title":"Analysis of tear uptake by the Schirmer tear test strip in the canine eye","volume":"8","author":"Williams","year":"2005","journal-title":"Vet Ophthalmol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib13","first-page":"274","article-title":"The phenol red thread test in dogs","volume":"6","author":"Brown","year":"1996","journal-title":"Progress in Veterinary and Comparative Ophthalmology"},{"key":"10.1016\/j.cvsm.2007.12.002_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1463-5224.2001.00124.x","article-title":"Estimation of lacrimal level and testing methods on normal beagles","volume":"4","author":"Saito","year":"2001","journal-title":"Vet Ophthalmol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/bjo.83.1.92","article-title":"Reflective meniscometry: a non-invasive method to measure tear meniscus curvature","volume":"83","author":"Yokoi","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1463-5224.1999.00074.x","article-title":"Tear production in dogs with epiphora and corneal epitheliopathy","volume":"2","author":"Saito","year":"1999","journal-title":"Vet Ophthalmol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib17","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tvjl.2006.10.008","article-title":"Canine meibometry: establishing baseline values for meibomian gland secretions in dogs","volume":"174","author":"Ofri","year":"2007","journal-title":"Vet J"},{"key":"10.1016\/j.cvsm.2007.12.002_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1463-5224.2005.00437.x","article-title":"Effect of age, gender, weight, and time of day on tear production in normal dogs","volume":"9","author":"Hartley","year":"2006","journal-title":"Vet Ophthalmol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib19","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1748-5827.2007.00349.x","article-title":"Reduced tear production in three canine endocrinopathies","volume":"48","author":"Williams","year":"2007","journal-title":"J Small Anim Pract"},{"key":"10.1016\/j.cvsm.2007.12.002_bib20","first-page":"112","article-title":"Keratoconjunctivitis sicca: histopathologic study of nictitating membrane and lacrimal glands from 28 dogs","volume":"45","author":"Kaswan","year":"1984","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cvsm.2007.12.002_bib21","doi-asserted-by":"crossref","first-page":"688","DOI":"10.2460\/ajvr.2002.63.688","article-title":"Histologic characteristics and local cellular immunity of the gland of the third eyelid after topical ophthalmic administration of 2% cyclosporine for treatment of dogs with keratoconjunctivitis sicca","volume":"63","author":"Izci","year":"2002","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cvsm.2007.12.002_bib22","unstructured":"Tighe A, Williams DL. Analysis of lymphocyte populations in nictitans glands of dogs with keratoconjunctivitis sicca. Veterinary Journal submitted."},{"key":"10.1016\/j.cvsm.2007.12.002_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.vetpar.2005.05.017","article-title":"Characterization of lacrimal gland lesions and possible pathogenic mechanisms of keratoconjunctivitis sicca in dogs with leishmaniosis","volume":"133","author":"Naranjo","year":"2005","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib24","first-page":"376","article-title":"Keratoconjunctivitis sicca: immunological evaluation of 62\u00a0canine cases","volume":"46","author":"Kaswan","year":"1985","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cvsm.2007.12.002_bib25","first-page":"1073","article-title":"Rheumatoid factor determination in 50 dogs with keratoconjunctivitis sicca","volume":"183","author":"Kaswan","year":"1983","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2007.12.002_bib26","first-page":"125","article-title":"Clinical and experimental studies with cyclosporine in renal transplantation","volume":"97","author":"Kahan","year":"1985","journal-title":"Surgery"},{"key":"10.1016\/j.cvsm.2007.12.002_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-3164.2002.00283.x","article-title":"Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial","volume":"13","author":"Olivry","year":"2002","journal-title":"Vet Dermatol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1748-5827.2005.tb00267.x","article-title":"Cyclosporine treatment of anal furunculosis in 26\u00a0dogs","volume":"46","author":"Hardie","year":"2005","journal-title":"J Small Anim Pract"},{"key":"10.1016\/j.cvsm.2007.12.002_bib29","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/j.1939-1676.2006.tb00771.x","article-title":"Management of myasthenia gravis using cyclosporine in 2 dogs","volume":"20","author":"Bexfield","year":"2006","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.cvsm.2007.12.002_bib30","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2460\/javma.1991.199.08.1043","article-title":"Topical administration of cyclosporine for treatment of keratoconjunctivitis sicca in dogs","volume":"99","author":"Morgan","year":"1991","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2007.12.002_bib31","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2460\/javma.1991.199.08.1039","article-title":"Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs","volume":"199","author":"Olivero","year":"1991","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2007.12.002_bib32","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/vr.137.20.504","article-title":"Treatment of keratoconjunctivitis sicca in dogs with cyclosporine ophthalmic ointment: a European clinical field trial","volume":"137","author":"Sansom","year":"1995","journal-title":"Vet Rec"},{"key":"10.1016\/j.cvsm.2007.12.002_bib33","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/eye.1997.126","article-title":"A comparative approach to topical cyclosporine therapy","volume":"11","author":"Williams","year":"1997","journal-title":"Eye"},{"key":"10.1016\/j.cvsm.2007.12.002_bib34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1463-5224.2005.00390.x","article-title":"Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca","volume":"8","author":"Berdoulay","year":"2005","journal-title":"Vet Ophthalmol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1463-5224.2005.04062.x","article-title":"The effect of topical pimecrolimus on keratoconjunctivitis sicca and chronic superficial keratitis in dogs: results from an exploratory study","volume":"8","author":"Nell","year":"2005","journal-title":"Vet Ophthalmol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib36","series-title":"Efficacy of topical tacrolimus in dogs with cyclosporine-non-responsive keratoconjunctivitis sicca","author":"Williams","year":"2006"},{"key":"10.1016\/j.cvsm.2007.12.002_bib37","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/vr.88.8.210-b","article-title":"A modified technique of parotid duct transposition for the treatment of keratoconjunctivitis sicca in the dog","volume":"88","author":"Glenn","year":"1971","journal-title":"Vet Rec"},{"key":"10.1016\/j.cvsm.2007.12.002_bib38","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1006\/exer.1998.0619","article-title":"Cyclosporin A increases tear fluid secretion via release of sensory neurotransmitters and muscarinic pathway in mice","volume":"68","author":"Yoshida","year":"1999","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.cvsm.2007.12.002_bib39","first-page":"653","article-title":"Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model","volume":"42","author":"Moore","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cvsm.2007.12.002_bib40","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1089\/107999099313433","article-title":"Low-dose oral administration of interferon-alpha for the treatment of immune-mediated keratoconjunctivitis sicca in dogs","volume":"19","author":"Gilger","year":"1999","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.cvsm.2007.12.002_bib41","first-page":"367","article-title":"Interferon alpha-2 (IFN alpha 2) increases lacrimal and salivary function in Sjogren's syndrome patients. Preliminary results of an open pilot trial versus OH-chloroquine","volume":"14","author":"Ferraccioli","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/jir.2006.0110","article-title":"The role of IFN-alpha as homeostatic agent in the inflammatory response: a balance between danger and response?","volume":"27","author":"Amadori","year":"2007","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.cvsm.2007.12.002_bib43","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.2460\/javma.1994.205.09.1286","article-title":"Effect of topical pilocarpine treatment on tear production in dogs","volume":"205","author":"Smith","year":"1994","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2007.12.002_bib44","first-page":"313","article-title":"Clinical use of pilocarpine for keratoconjuctivitis in dogs and cats","volume":"151","author":"Rubin","year":"1967","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2007.12.002_bib45","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4049\/jimmunol.130.1.203","article-title":"Immunohistologic analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies","volume":"130","author":"Adamson","year":"1983","journal-title":"J Immunol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib46","first-page":"475","article-title":"Epithelial HLA-DR expression and T lymphocyte subsets in salivary glands in Sjogren's syndrome","volume":"61","author":"Lindahl","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib47","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1172\/JCI118629","article-title":"Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjogren's syndrome","volume":"97","author":"Matsumoto","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cvsm.2007.12.002_bib48","first-page":"2092","article-title":"Identification of Ro(SSA) 52 kDa reactive T cells in labial salivary glands from patients with Sjogren's syndrome","volume":"22","author":"Namekawa","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib49","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2249.2003.02263.x","article-title":"Stress protein-polypeptide complexes acting as autoimmune triggers","volume":"134","author":"Eggleton","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib50","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.autrev.2007.01.010","article-title":"Polarization of B effector cells in Sjogren's syndrome","volume":"6","author":"Daridon","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cvsm.2007.12.002_bib51","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1177\/000348940010901217","article-title":"Pathological features of lymphoid proliferations of the salivary glands: lymphoepithelial sialadenitis versus low-grade B-cell lymphoma of the malt type","volume":"109","author":"Carbone","year":"2000","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib52","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/030097499442577","article-title":"Th1 cytokines are produced in labial salivary glands in Sjogren's syndrome, but also in healthy individuals","volume":"28","author":"Konttinen","year":"1999","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib53","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/ard.2005.040956","article-title":"Th2 cytokine genotypes are associated with a milder form of primary Sjogren's syndrome","volume":"65","author":"Pertovaara","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cvsm.2007.12.002_bib54","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1046\/j.1365-2249.2002.01869.x","article-title":"The Th1\/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome","volume":"128","author":"Mitsias","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib55","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1167\/iovs.03-1055","article-title":"Animal models of dry eye: a critical assessment of opportunities and limitations","volume":"45","author":"Barabino","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cvsm.2007.12.002_bib56","first-page":"371","article-title":"Murine models of Sjogren's syndrome. Evolution of the lacrimal gland inflammatory lesions","volume":"32","author":"Jabs","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cvsm.2007.12.002_bib57","first-page":"399","article-title":"The role of Fas-Fas ligand-mediated apoptosis in autoimmune lacrimal gland disease in MRL\/MpJ mice","volume":"42","author":"Jabs","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cvsm.2007.12.002_bib58","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1076\/ceyr.16.9.909.5050","article-title":"Role of T cells in the pathogenesis of autoimmune lacrimal gland disease in MRL\/Mp-lpr\/lpr mice","volume":"16","author":"Jabs","year":"1997","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.cvsm.2007.12.002_bib59","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/0008-8749(92)90166-M","article-title":"Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL\/Mp-lpr\/lpr mice","volume":"141","author":"Jabs","year":"1992","journal-title":"Cell Immunol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib60","first-page":"2567","article-title":"Cytokines in autoimmune lacrimal gland disease in MRL\/MpJ mice","volume":"42","author":"Jabs","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cvsm.2007.12.002_bib61","first-page":"826","article-title":"Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL\/Mp mice","volume":"41","author":"Jabs","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cvsm.2007.12.002_bib62","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1167\/iovs.03-0812","article-title":"Chemokines in autoimmune lacrimal gland disease in MRL\/MpJ mice","volume":"45","author":"Akpek","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cvsm.2007.12.002_bib63","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1167\/iovs.03-0958","article-title":"Inflammatory mediators in autoimmune lacrimal gland disease in MRL\/MpJ mice","volume":"45","author":"Jabs","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cvsm.2007.12.002_bib64","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/1529-0131(199801)41:1<150::AID-ART18>3.0.CO;2-T","article-title":"A novel NOD-derived murine model of primary Sjogren's syndrome","volume":"41","author":"Robinson","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cvsm.2007.12.002_bib65","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/08916939809008035","article-title":"Characterization of the changing lymphocyte populations and cytokine expression in the exocrine tissues of autoimmune NOD mice","volume":"27","author":"Robinson","year":"1998","journal-title":"Autoimmunity"},{"key":"10.1016\/j.cvsm.2007.12.002_bib66","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2005.11.004","article-title":"Sjogren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease","volume":"26","author":"Gao","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1016\/j.cvsm.2007.12.002_bib67","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2249.2005.02930.x","article-title":"Defective signalling in salivary glands precedes the autoimmune response in the non-obese diabetic mouse model of sialadenitis","volume":"142","author":"Rosignoli","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib68","first-page":"247","article-title":"Salivary gland changes in the NOD mouse model for Sjogren's syndrome: is there a non-immune genetic trigger?","volume":"36","author":"Humphreys-Beher","year":"1998","journal-title":"Eur J\u00a0Morphol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib69","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0003-9969(99)90008-0","article-title":"New concepts for the development of autoimmune exocrinopathy derived from studies with the NOD mouse model","volume":"44","author":"Humphreys-Beher","year":"1999","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib70","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1073\/pnas.95.13.7538","article-title":"Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjogren's syndrome","volume":"95","author":"Robinson","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cvsm.2007.12.002_bib71","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/1529-0131(200010)43:10<2297::AID-ANR18>3.0.CO;2-X","article-title":"Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in NOD mice","volume":"43","author":"Nguyen","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cvsm.2007.12.002_bib72","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.molimm.2005.09.003","article-title":"Role of complement and B lymphocytes in Sjogren's syndrome-like autoimmune exocrinopathy of NOD.B10-H2b mice","volume":"43","author":"Nguyen","year":"2006","journal-title":"Mol Immunol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib73","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.exer.2005.10.018","article-title":"Effect of inflammation on lacrimal gland function","volume":"82","author":"Zouhkri","year":"2006","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.cvsm.2007.12.002_bib74","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/00003226-199811000-00014","article-title":"The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: the effect of topical Cyclosporin A therapy","volume":"17","author":"Gao","year":"1998","journal-title":"Cornea"},{"key":"10.1016\/j.cvsm.2007.12.002_bib75","first-page":"925","article-title":"Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjogren's syndrome","volume":"2","author":"Zoukhri","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cvsm.2007.12.002_bib76","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/978-1-4615-5359-5_139","article-title":"Oral pilocarpine for symptomatic relief of dry mouth and dry eyes in patients with Sjogren's syndrome","volume":"438","author":"Papas","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib77","first-page":"2371","article-title":"Excessive synthesis of matrix metalloproteinases in exocrine tissues of NOD mouse models for Sjogren's syndrome","volume":"25","author":"Yamachika","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib78","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/art.1780210308","article-title":"Relationship of HLA-Dw3 and HLA-B8 to Sjogren's syndrome","volume":"21","author":"Fye","year":"1978","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cvsm.2007.12.002_bib79","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1006\/exer.1999.0715","article-title":"Impact of gender on exocrine gland inflammation in mouse models of Sjogren's syndrome","volume":"69","author":"Toda","year":"1999","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.cvsm.2007.12.002_bib80","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1196\/annals.1422.045","article-title":"The influence of sex steroids on Sjogren's syndrome","volume":"1108","author":"Porola","year":"2007","journal-title":"Ann N\u00a0Y Acad Sci"},{"key":"10.1016\/j.cvsm.2007.12.002_bib81","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0960-0760(96)00190-2","article-title":"Androgen stimulation of lacrimal gland function in mouse models of Sjogren's syndrome","volume":"60","author":"Sullivan","year":"1997","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib82","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0014-4835(05)80016-8","article-title":"Immunocytochemical location and hormonal control of androgen receptors in lacrimal tissues of the female MRL\/Mp-lpr\/lpr mouse model of Sjogren's syndrome","volume":"61","author":"Ono","year":"1995","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.cvsm.2007.12.002_bib83","first-page":"2537","article-title":"Impact of androgen therapy in Sjogren's syndrome: hormonal influence on lymphocyte populations and Ia expression in lacrimal glands of MRL\/Mp-lpr\/lpr mice","volume":"33","author":"Sato","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cvsm.2007.12.002_bib84","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/clin.1997.4466","article-title":"Gender and androgen treatment influence the expression of proto-oncogenes and apoptotic factors in lacrimal and salivary tissues of MRL\/lpr mice","volume":"86","author":"Toda","year":"1998","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib85","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000049194","article-title":"Abnormal organogenesis in salivary gland development may initiate adult onset of autoimmune exocrinopathy","volume":"18","author":"Cha","year":"2001","journal-title":"Exp Clin Immunogenet"},{"key":"10.1016\/j.cvsm.2007.12.002_bib86","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.archoralbio.2005.11.008","article-title":"Detection of cleaved alpha-fodrin autoantigen in Sjogren's syndrome: apoptosis and co-localisation of cleaved alpha-fodrin with activated caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) in labial salivary glands","volume":"51","author":"Wang","year":"2006","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib87","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.4049\/jimmunol.163.4.2226","article-title":"Preferential localization of CD8+ alpha E beta 7+ T cells around acinar epithelial cells with apoptosis in patients with Sjogren's syndrome","volume":"163","author":"Fujihara","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib88","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1002\/1529-0131(200110)44:10<2376::AID-ART402>3.0.CO;2-E","article-title":"Novel fragments of the Sjogren's syndrome autoantigens alpha-fodrin and type 3 muscarinic acetylcholine receptor generated during cytotoxic lymphocyte granule-induced cell death","volume":"44","author":"Nagaraju","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cvsm.2007.12.002_bib89","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4049\/jimmunol.169.2.1050","article-title":"Prevention and induction of autoimmune exocrinopathy is dependent on pathogenic autoantigen cleavage in murine Sjogren's syndrome","volume":"169","author":"Saegusa","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib90","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/rheumatology\/kel067","article-title":"Sjogren's syndrome\u2014the non-apoptotic model of glandular hypofunction","volume":"45","author":"Dawson","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cvsm.2007.12.002_bib91","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","article-title":"Tolerance, danger and the extended family","volume":"12","author":"Matzinger","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.cvsm.2007.12.002_bib92","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/rheumatology\/keh647","article-title":"Sjogren's syndrome and the danger model","volume":"44","author":"Bredberg","year":"2005","journal-title":"Rheumatology (Oxford)"}],"container-title":["Veterinary Clinics of North America: Small Animal Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561607001477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561607001477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T14:51:08Z","timestamp":1708613468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195561607001477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":92,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0195561607001477"],"URL":"https:\/\/doi.org\/10.1016\/j.cvsm.2007.12.002","relation":{},"ISSN":["0195-5616"],"issn-type":[{"value":"0195-5616","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}